Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × TP protocol × Thoracic × Clear all

Phase

Status

Unknown 2 Terminated 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4 Head & Neck 2 Thoracic 1 Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 384 Cisplatin 318 Pemetrexed 258 Paclitaxel 249 Docetaxel 206 Gemcitabine 199 Erlotinib Hydrochloride 198 Radiotherapy 147 Bevacizumab 144 pembrolizumab 130 Nivolumab 102 Etoposide 88 Vinorelbine 75 Gefitinib 73 Topotecan 55 durvalumab 54 Cetuximab 54 atezolizumab 53 Drug Therapy 47 Irinotecan 45 Radiosurgery 42 Ipilimumab 42 osimertinib 40 Afatinib 39 Albumin-Bound Paclitaxel 30 Cyclophosphamide 29 130-nm albumin-bound paclitaxel 29 Surgical Procedures, Operative 28 Taxes 27 Surveys and Questionnaires 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00680940 2012-08-07

NSCLC

Cadila Pharnmaceuticals

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡